Ep 344. Robots Are Coming To The Cath Lab

[June 24, 2026] Robots Are Coming To The Cath Lab. What if the future of interventional cardiology isn’t just better devices—but robotic precision?

In this episode of Med Tech Gurus, we sit down with Dr. Philippe Bencteux, founder and president of RoboCath, a pioneering company developing robotic platforms designed to transform cardiovascular and neurovascular interventions.

A neuroradiologist turned entrepreneur, Dr. Bencteux launched RoboCath after witnessing how access to specialized vascular expertise can determine whether patients live or die—particularly in hospitals lacking advanced interventional capabilities. His vision: bring robotic precision and eventually remote care to life-saving endovascular procedures.

We explore the evolution of RoboCath’s robotic systems, including the R1 platform, which demonstrated more than 98% technical success in multicenter studies, and the company’s next-generation system now entering first-in-human trials for coronary artery disease.

Dr. Bencteux shares how robotics can dramatically improve physician safety by reducing radiation exposure and physical strain in the cath lab, while also increasing procedural precision and enabling more complex interventions.

If you're interested in robotic surgery, interventional cardiology innovation, digital health, AI-driven medical devices, or the future of remote healthcare, this episode offers a fascinating look at how robotics could reshape the next era of cardiovascular treatment.